Concepedia

Publication | Closed Access

Phase II Study of a Combination of Irinotecan and Cisplatin Against Metastatic Gastric Cancer

263

Citations

25

References

1999

Year

Abstract

This combination chemotherapy regimen is active and well tolerated. It may be an appropriate regimen for future phase III trials.

References

YearCitations

Page 1